CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022

Bibliographic Data

ID23328834
AuthorsDeborah Dowell (0000-0002-1615-224X, National Center for Injury Prevention and Control, corresponding author), Kathleen R Ragan, Kathleen Ragan (National Center for Injury Prevention and Control), Christopher M Jones (0000-0002-6504-6224, United States Department of Health and Human Services), Grant T Baldwin (0000-0003-1028-1494, National Center for Injury Prevention and Control), Rosalind Chou (0000-0001-9889-8610, Oregon Health & Science University), Roger Chou
Year2022
Volume71
Issue3
Pages1-95
Publication date2022-11-04
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueMMWR. Surveillance Summaries (JOURNAL)
Journal identifiersISSN: 1546-0738 • E-ISSN: 1545-8636
PublisherCenters for Disease Control MMWR Office (PUBLISHER)
DOI10.15585/mmwr.rr7103a1
PMID36327391
OpenAlexW4308369850
LanguageEN
Citations received66
References cited412

This guideline provides recommendations for clinicians providing pain care, including those prescribing opioids, for outpatients aged ≥18 years. It updates the CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016 (MMWR Recomm Rep 2016;65[No. RR-1]:1-49) and includes recommendations for managing acute (duration of 3 months) pain. The recommendations do not apply to pain related to sickle cell disease or cancer or to patients receiving palliative or end-of-life care. The guideline addresses the following four areas: 1) determining whether or not to initiate opioids for pain, 2) selecting opioids and determining opioid dosages, 3) deciding duration of initial opioid prescription and conducting follow-up, and 4) assessing risk and addressing potential harms of opioid use. CDC developed the guideline using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework. Recommendations are based on systematic reviews of the scientific evidence and reflect considerations of benefits and harms, patient and clinician values and preferences, and resource allocation. CDC obtained input from the Board of Scientific Counselors of the National Center for Injury Prevention and Control (a federally chartered advisory committee), the public, and peer reviewers. CDC recommends that persons with pain receive appropriate pain treatment, with careful consideration of the benefits and risks of all treatment options in the context of the patient's circumstances. Recommendations should not be applied as inflexible standards of care across patient populations. This clinical practice guideline is intended to improve communication between clinicians and patients about the benefits and risks of pain treatments, including opioid therapy; improve the effectiveness and safety of pain treatment; mitigate pain; improve function and quality of life for patients with pain; and reduce risks associated with opioid pain therapy, including opioid use disorder, overdose, and death.

Chronic pain · Context (archaeology) · Family medicine · Grading (engineering) · Guideline · Intensive care medicine · Medical prescription · MEDLINE · Opioid · Palliative care · Physical therapy · Internal Medicine · Medicine · Nursing · Opioid Use Disorder Treatment · Pain Management and Opioid Use · Pediatric Pain Management Techniques

Tools

Open DOIOpen Access